Group items tagged

Overview: During the webinar Participants will be addresses on the key regulatory provisions for cosmetic products in the major global economies. The EU's new Cosmetic Product Regulation (EU CPR) will be given a certain, wider position as the EU CPR is representing the latest, most modern regulatory framework which is influencing other global legislators. For the regulations of the USA, Canada, China, Japan, South Korea, Taiwan, ASEAN, India, Brazil, Mercosul/Mercosur and Russia, a general introduction into the key provisions will be given. Some specific difficulties arising from the existing discrepancies in the global frameworks will be depicted. Areas Covered in the Session: The new EU Cosmetics Regulation Basis principles and provisions Experiences and obstacles from the implementation phase Options for compliance approaches and available supporting tools Remaining issues and future perspectives and activities Cosmetics Regulations in Asia China & Hong Kong South Korea Japan Taiwan The ASEAN Cosmetics Directive India Russia Cosmetics Regulation in the Americas - Existing Global Discrepancies and International Harmonization Attempts USA Canada Mercosur / Mercosul South Africa Existing Global Discrepancies Harmonization Attempts The Intern. Cooperation on Cosmetic Regulation (ICCR) Who Will Benefit: Business Owners Managers in manufacturing New staff in manufacturing QA Administrative Managers Regulatory Compliance Associates Customer Service Speaker Profile Dr. Annelie Struessmann is Technical Director with CONUSBAT, a provider of internationalization services for the Fine Chemicals, Cosmetics & Life Sciences Industries: www.conusbat.com. She joined the firm in 2003 and established the service area of regulatory affairs where she is focusing on the European regulatory frameworks for cosmetic products and for chemicals (REACH). The service spectrum includes dossier preparation, safety assessments, registrations, notifications and direct representations, etc. S

Overview: Do you know the steps that going into making new clients aware of your practice? From the first time they become aware of you brand, every step you take and every interaction along the way is more important than you know! Learn how to keep your customers coming back for more and singing your praises to those that matter, as well as a surefire formula to make sure your marketing dollars are working as well as you think they are! (Hint: We'll be GIVING YOU the formula to use from here on out!) Areas Covered in the Session: Each step of the customer acquisition, retention and upsell process Formula to determine the ROI of marketing expenses Who Will Benefit: Medical Practice Owners Managers Marketing Associates Speaker Profile Mara L. Shorr BA, MBM-C, CAC I-VIII is the founder and managing partner of The Best Medical Business Solutions, a Florida-based medical practice consulting firm assisting practices with their operational, administrative and financial health. Jay served as the Vice President of Operations and Practice Administrator for a leading Board Certified Dermatologist and Cosmetic Surgeon in South Florida until her passing in June 2012, and is currently a partner in a leading South Florida plastic surgery center and medspa. A Temple University graduate, Jay has served as a professional motivational speaker for nearly a dozen industry organizations, including the American Academy of Cosmetic Surgery, THE Aesthetic Show, The Aesthetic Academy, The Medical Entrepreneur Symposium, the American Academy of Facial and Reconstructive Plastic Surgery, the American Academy of Anti-Aging Medicine, the American Academy of Cosmetic Surgery, Vegas Cosmetic Surgery and Global Aesthetics, and more! In addition, he is a Certified Medical Business Manager from Florida Atlantic University. He is a Certified Medical Business Manager (CMBM) from Florida Atlantic University and a Certified Aesthetic Consultant (Levels I-VII) from The Aesthetic Practice Associa

Tech innovation in the healthcare industry is seeing some exciting developments that are changing lives and the latest of these is an ATM pharmacy.

Tech innovation in the healthcare industry is seeing some exciting developments that are changing lives and the latest of these is an ATM pharmacy.

US-based medical diagnostics maker T2 Biosystems has signed six new agreements for the exclusive distribution of its diagnostic technologies in Estonia, Greece, Ireland, Saudi Arabia, and South Africa.

Nutricosmetics refers to nutritional supplements that are used to enhance aesthetic appeal. Skin care usually includes the application of creams, lotions and other skin products. Nutricosmetics can be used to make skin look younger and healthier. The ingredients used to make these products usually include vitamins, antioxidants, and other nutrients that the skin needs to function properly. There are other forms that can be used in making the skin look younger. Increasing aesthetic appeal is expected to propel growth of the nutricosmetics market. For instance, according to a 2018 survey by GlobalData, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Increasing expenditure on personal care products is expected to offer lucrative growth opportunities for players in the nutricosmetics market. For instance, according to the U.S. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/increasing-aesthetic-appeal-and.html

Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease of the liver. The auto-immune disorder can have a number of symptoms such as abdominal pain, fever, nausea, vomiting, abdominal bloating, diarrhea, liver tenderness or enlargement, jaundice, and ascites. In most of these symptoms, the patient may be experiencing inflammation at an early stage of the illness, although in some cases, symptoms do not appear until the disease has advanced to a more serious state. A definitive diagnosis can only be made by performing blood tests and ultrasound studies in order to determine the progression of the illness and its effects on the body. At an early stage, most patients who experience mild to moderate symptoms of primary biliary cholangitis exhibit no symptoms, whereas in some cases, symptoms manifest very quickly and rapidly worsen. In both conditions, the majority of affected individuals undergo treatment that is aimed at relieving pain and treating any complications that might occur. High prevalence of primary biliary cholangitis is expected to propel growth of the primary biliary cirrhosis drugs market. For instance, according to the study, 'Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis', published in Hepatology International in September 2019, the overall prevalence of primary biliary cholangitis was 118.75 cases per million in the Asia Pacific region, with the high, medium and low prevalence being in Japan and China (191.18 cases per million), New Zealand (99.16 cases per million) and South Korea and Australia (39.09 cases per million), respectively. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-primary-biliary.html

Increasing Focus on Aesthetic Appeal and Growing Geriatric Population to Augment Growth of Skin Rejuvenation Devices Market Skin rejuvenation is basically a cosmetic surgery, which aims to bring about a more youthful appearance of the face. Various facial rejuvenation techniques can be used to accomplish this goal. Such procedures can range in depth and Invasiveness of treatment. It is important for you to understand the kind of skin care treatment that would be best suited for your specific goals and preferences. Increasing focus on aesthetic appeal is expected to propel growth of the skin rejuvenation devices market. For instance, according to a 2018 survey by Global Data, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Increasing expenditure on personal care products is expected to offer lucrative growth opportunities for players in the skin rejuvenation devices market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/increasing-focus-on-aesthetic-appeal.html

Cosmetic dentistry is normally used to describe any type of dental work which improves the look of bite, gums, and teeth. It is also commonly used to describe any work done to improve the health of the mouth and to correct any abnormalities. Generally, cosmetic dentistry deals with aesthetic dental surgery, which aims at improving the 'appearance' of the teeth rather than their 'function'. Increasing focus on aesthetic appeal is expected to propel growth of the cosmetic dentistry market. For instance, according to a 2018 survey by Global Data, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing expenditure on personal care products is also expected to aid in growth of the market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/increasing-focus-on-aesthetic-appeal-to_30.html

Dr P.P. Singh has emerged as the best Urology Surgeon in Delhi catering the best treatment at the modest prices. He holds great knowledge in this field. Go through the official site to accumulate more information.

Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world. Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning. The increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600 new cases of stomach cancer are expected to be diagnosed in the U.S. According to the World Cancer Research Fund, in 2018, over 1 million new cases of cancer were diagnosed across the globe. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/stomach-cancer-drugs-market-continues.html